Clinical Diagnostic Market is driven by growing preference toward minimally invasive diagnostic procedures
Clinical Diagnostic Market |
The
clinical diagnostic market encompasses various products that are used to
determine the nature or cause of various clinical abnormalities or diseases.
Some key products in this market include clinical chemistry analyzers,
hematology analyzers, flow cytometers, immunoassay analyzers, microbiology
systems, molecular diagnostic instruments, and others. The growing preference
toward minimally invasive diagnostic procedures has boosted the demand for
these clinical diagnostic instruments in recent years. Minimally invasive
diagnostic procedures require only a small sample and provide quicker results
while avoiding risks associated with invasive surgeries.
The
global clinical diagnostic market is estimated to be valued at US$ 96.01 Bn in
2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to
2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends in the clinical diagnostic market is the growing
adoption of decentralized diagnostic tests. Decentralized tests involve
conducting diagnostic tests at or near the site of patient care instead of
sending samples to a central lab. This improves diagnostic timelines and
enables quicker clinical decisions. Various point-of-care testing devices have
emerged that allow conducting diagnostic tests outside a laboratory setting
using small blood or urine samples. Growing focus on early detection and
prevention has further driven use of such decentralized clinical diagnostic
tests. Another trend gaining momentum is increasing automation in clinical
diagnostic laboratories. Many diagnostic laboratories are automating
pre-analytical, analytical and post-analytical processes using advanced
robotics to improve workflow efficiency and throughput. This is allowing labs
to scale up operations while maintaining testing accuracy. Laboratories are
also increasingly integrating Artificial Intelligence and IoT technologies to
gain real-time insights, enable predictive diagnostics, and enhance clinical
outcomes.
Porter's Analysis
Threat of new entrants: The clinical diagnostic market
has moderate barriers for new entrants owing to large capital requirements and
established brand loyalty of existing players. However, improving technologies
and increasing demand are opening up opportunities.
Bargaining power of buyers: The bargaining power of buyers is moderate due to
the availability of substitute diagnostic methods and growing healthcare costs
pressure. However, customization as per requirements increases buyer power.
Bargaining power of suppliers: The bargaining power of suppliers is low as there
are many raw material suppliers and diagnostic product manufacturers. Suppliers
cannot influence pricing.
Threat of new substitutes: The threat of new substitutes is moderate as new
diagnostic technologies are emerging but existing technologies have a strong
customer base loyalty.
Competitive rivalry: Competition in the clinical diagnostic market is high due
to the presence of several global and regional players offering a wide range of
diagnostic tests. Players differentiate based on innovation and pricing.
Key Takeaways
The Global
Clinical Diagnostic Market Demand is expected to witness high growth.
The global clinical diagnostic market is estimated to be valued at US$ 96.01 Bn
in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024
to 2031.
Regional analysis: North America dominates the clinical diagnostic market owing
to high awareness, advanced healthcare infrastructure, and presence of leading
market players. Asia Pacific is expected to witness the fastest growth rate
during the forecast period due to growing medical tourism, increasing
healthcare expenditure, and improving diagnostic infrastructure in emerging
countries like China and India.
Key players operating in the clinical diagnostic market are NVIDIA Corporation,
Advanced Micro Devices Inc., Amazon Web Series, NEC Corporation, Lenovo Group
Ltd., Hewlett Packard Enterprise, Dassault Systemes SE, Sugon Information Industry
Co. Ltd., Dell Technologies Inc., Fujistu Ltd., Microsoft Corporation, Intel
Corporation, and International Business Machines Corporation. Technological
advancements including use of artificial intelligence and cloud computing are
helping key players like NVIDIA Corporation and Advanced Micro Devices Inc. to
differentiate their offerings.
For more insights, Read- https://www.insightprobing.com/clinical-diagnostic-market-demand-share-analysis/
Get
more insights on this topic: https://www.ukwebwire.com/neurological-biomarkers-market-trends-size-and-share-analysis-2/
Comments
Post a Comment